Exon-level expression analyses identify MYCN and NTRK1 as major determinants of alternative exon usage and robustly predict primary neuroblastoma outcome
A Schramm, B Schowe, K Fielitz, M Heilmann, M Martin, T Marschall, J Köster, J Vandesompele, J Vermeulen, K de Preter, J Koster, R Versteeg, R Noguera, F Speleman, S Rahmann, A Eggert, K Morik, J H Schulte
October 2012